What we achieved in 2025, together
Date
Research news
Date
We're providing £1.24m through our Virtual Biotech programme to help test a potential treatment called MTX325 in people with Parkinson’s.
Date
We're providing £1.55m through our Virtual Biotech programme to carry out the first clinical trials to see if HER-096 is safe for people with Parkinson’s and to start exploring its potential benefits.
Date
Parkinson's UK is funding researchers to develop a potential set of drugs against a new target for people with Parkinson's.
Date
Research co-funded by Parkinson’s UK finds a new way to potentially improve diagnosis and monitoring of Parkinson’s.
Date
We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
Date
A partnership involving Parkinson’s UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
Date
We're providing £2.1million through our Virtual Biotech programme to develop a potential new drug which holds promise for protecting brain cells in Parkinson's.
Date
The TOP HAT trial is closing early and we have an important update on next steps.
Date
Parkinson’s UK has funded two future leaders in Parkinson’s research who are pushing forward our understanding of the early stages and causes of Parkinson’s.
Date
Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson’s, called a faecal microbiota transplant, is safe and may ease motor symptoms.